Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura

Original Article

M. Scully, S.R. Cataland, F. Peyvandi, P. Coppo, P. Knöbl, J.A.K. Hovinga, A. Metjian, J.d.l. Rubia, K. Pavenski, F. Callewaert, D. Biswas, H.D. Winter, and R.K. Zeldin

N Engl J Med 2019;380:335-346

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
01/23/2019
Course expires: 
01/24/2021

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Sunday, January 24, 2021 - 11:59pm.